Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cognition Therapeutics Inc’s current trading price is -71.79% away from its 52-week high, while its distance from the 52-week low is 221.68%. The stock’s price range over this period has fluctuated between $0.22 and $2.54. The company, operating within the financial sector, had a trading volume of approximately 6.71 million for the day, which was noticeably lower than the average daily share volume of 7.24 million over the last 3 months.
Cognition Therapeutics Inc (CGTX) stock is currently valued at $0.72. During the last session, the stock experienced a remarkable rise, reaching $4.0 after opening at $0.72. The stock briefly dropped to $2.0 before ultimately closing at $0.84.
Cognition Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $2.54 on 07/29/24, while the lowest price for the same duration was marked at $0.22 on 05/28/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cognition Therapeutics Inc (CGTX) has experienced a quarterly rise of 63.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 44.33M and boasts a workforce of 28 employees.
Cognition Therapeutics Inc: What Analysts Are Saying
As of right now, 3 analysts are rating Cognition Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4106, with a change in price of +0.2944. Similarly, Cognition Therapeutics Inc recorded 4,778,619 in trading volume during the last 100 days, posting a change of +69.98%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CGTX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.02.
CGTX Stock Stochastic Average
Today’s raw stochastic average for Cognition Therapeutics Inc over the last 50 days is 60.27%.This indicates a increase from the raw stochastic average of the past 20 days, which was 56.49%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 68.60% and 70.43%, respectively.
CGTX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -61.14%. However, over the last six months, the performance has been stronger by -5.15%. The price of CGTX increased 120.37% over the last 30 days. And in the last five days, it has surged by 2.16%.
